Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …

The well-recognized individual heterogeneity within COPD patients has led to a growing
interest in greater personalization in the approach of these patients. Thus, the treatable traits …

For decades, chronic obstructive pulmonary disease (COPD) has been considered a
relentlessly progressive disease in which the deterioration of lung function is associated with …

The complexity of COPD implies the need to identify groups of patients with similar clinical
characteristics and prognosis or treatment requirements. This is why much attention has …

ABSTRACT Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and
complex disease with great morbidity and mortality. Despite the new developments in the …

Categorization of patients with COPD as reversible or nonreversible to a bronchodilator may
change over time. This post hoc analysis aimed to determine if an individual's reversibility …

Background The aim of the study was to analyze the characteristics and survival of a group
of patients with COPD according to their clinical phenotype. Patients and methods The study …

Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of
lung conditions challenging to diagnose and treat. Identification of phenotypes of patients …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease associated with
significant morbidity and mortality. Over the past few years, there has been cumulating …

Background Bronchodilator responsiveness is a potential phenotypic characteristic of
chronic obstructive pulmonary disease (COPD). We studied whether change in lung function …